Pelvic inflammatory disease

New England Journal of Medicine

Volumn 372, Issue 21, 2015, Pages 2039-2048

  Brunham, Robert C ^a   Gottlieb, Sami L ^b   Paavonen, Jorma ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AZITHROMYCIN; C REACTIVE PROTEIN; CA 125 ANTIGEN; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFOXITIN PLUS PROBENICID; CEFTIZOXIME; CEFTRIAXONE; CLINDAMYCIN; DOXYCYCLINE; METRONIDAZOLE; PROBENECID; UNCLASSIFIED DRUG; UVOMORULIN; ANTIINFECTIVE AGENT;

ACUTE APPENDICITIS; ARTICLE; BACTERIAL STRAIN; BACTEROIDES FRAGILIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DISEASE SEVERITY; DYSPAREUNIA; DYSURIA; ECTOPIC PREGNANCY; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; ERYTHROCYTE SEDIMENTATION RATE; ESCHERICHIA COLI; FEMALE GENITAL TRACT INFECTION; FEMALE INFERTILITY; FEVER; GONORRHEA; HAEMOPHILUS INFLUENZAE; HISTOPATHOLOGY; HUMAN; INFECTION RISK; INTRAUTERINE CONTRACEPTIVE DEVICE; LAPAROSCOPY; LONG TERM CARE; LOWER ABDOMINAL PAIN; METRORRHAGIA; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA GENITALIUM; MYCOPLASMA HOMINIS; NEISSERIA GONORRHOEAE; NONHUMAN; NONSPECIFIC URETHRITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVARY CYST; PATHOGENESIS; PELVIC INFLAMMATORY DISEASE; PELVIS PAIN SYNDROME; PREGNANCY TEST; PREVENTION AND CONTROL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALPINGITIS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEXUAL EDUCATION; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; STANDARDIZATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TRANSVAGINAL ECHOGRAPHY; UNITED STATES; UREAPLASMA UREALYTICUM; VAGINA DISCHARGE; VAGINITIS; FEMALE; INFERTILITY, FEMALE;

ANTI-BACTERIAL AGENTS; CEFOXITIN; DOXYCYCLINE; FEMALE; HUMANS; INFERTILITY, FEMALE; PELVIC INFLAMMATORY DISEASE;

EID: 84929833137     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1411426     Document Type: Review

References (73)

1. Paavonen J, Westrom L, Eschenbach D. Pelvic inflammatory disease. In: Holmes KK, Sparling PF, Stamm WE, et al., eds. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill, 2008.
2. Kiviat NB, Wølner-Hanssen P, Eschenbach DA, et al. Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol 1990;14:167-75.
3. Soper DE. Pelvic inflammatory disease. Obstet Gynecol 2010;116:419-28.
4. Wiesenfeld HC, Hillier SL, Meyn LA, Amortegui AJ, Sweet RL. Subclinical pelvic inflammatory disease and infertility. Obstet Gynecol 2012;120:37-43.
5. Sutton MY, Sternberg M, Zaidi A, St Louis ME, Markowitz LE. Trends in pelvic inflammatory disease hospital discharges and ambulatory visits, United States, 1985-2001. Sex Transm Dis 2005;32:778-84.
6. Bender N, Herrmann B, Andersen B, et al. Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study. Sex Transm Infect 2011;87:601-8.
7. Bohm MK, Newman L, Satterwhite CL, Tao G, Weinstock HS. Pelvic inflammatory disease among privately insured women, United States, 2001-2005. Sex Transm Dis 2010;37:131-6.
8. French CE, Hughes G, Nicholson A, et al. Estimation of the rate of pelvic inflammatory disease diagnoses: trends in England, 2000-2008. Sex Transm Dis 2011;38:158-62.
9. Rekart ML, Gilbert M, Meza R, et al. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis 2013;207:30-8.
10. Anschuetz GL, Asbel L, Spain CV, et al. Association between enhanced screening for Chlamydia trachomatis and Neisseria gonorrhoeae and reductions in sequelae among women. J Adolesc Health 2012;51:80-5.
11. Ross JD, Hughes G. Why is the incidence of pelvic inflammatory disease falling? BMJ 2014;348:g1538.
12. Wiesenfeld H, Cates WJ. Sexually transmitted diseases and infertility. In: Holmes KK, Sparling PF, Stamm WE, et al., eds. Sexually transmitted diseases. 4th ed. New York: McGraw-Hill, 2008.
13. Manhart LE, Broad JM, Golden MR. Mycoplasma genitalium: should we treat and how? Clin Infect Dis 2011;53:Suppl 3: S129-S142.
14. Bjartling C, Osser S, Persson K. Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. Am J Obstet Gynecol 2012;206(6):476.e1-476.e8.
15. Bjartling C, Osser S, Persson K. The association between Mycoplasma genitalium and pelvic inflammatory disease after termination of pregnancy. BJOG 2010;117:361-4.
16. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 2010;201:Suppl 2:S134-S155.
17. Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (Prevention of Pelvic Infection) trial. BMJ 2010;340:c1642.
18. Price MJ, Ades AE, De Angelis D, et al. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol 2013;178:484-92.
19. Hebb JK, Cohen CR, Astete SG, Bukusi EA, Totten PA. Detection of novel organisms associated with salpingitis, by use of 16S rDNA polymerase chain reaction. J Infect Dis 2004;190:2109-20.
20. Eschenbach DA, Buchanan TM, Pollock HM, et al. Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med 1975;293:166-71.
21. Wasserheit JN, Bell TA, Kiviat NB, et al. Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med 1986;104:187-93.
22. Brunham RC, Binns B, Guijon F, et al. Etiology and outcome of acute pelvic inflammatory disease. J Infect Dis 1988;158:510-7.
23. Soper DE, Brockwell NJ, Dalton HP, Johnson D. Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol 1994;170:1008-14.
24. Brotman RM. Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. J Clin Invest 2011;121:4610-7.
25. McGregor JA, French JI, Jones W, et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994;170:1048-59.
26. Draper DL, Landers DV, Krohn MA, Hillier SL, Wiesenfeld HC, Heine RP. Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. Am J Obstet Gynecol 2000;183:1243-8.
27. Ness RB, Kip KE, Hillier SL, et al. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol 2005;162:585-90.
28. Patton DL, Moore DE, Spadoni LR, Soules MR, Halbert SA, Wang SP. A comparison of the fallopian tube's response to overt and silent salpingitis. Obstet Gynecol 1989;73:622-30.
29. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. National Health Statistics Reports No. 8. Hyattsville, MD: National Center for Health Statistics, 2008:1-29 (http://www.cdc.gov/nchs/data/nhsr/nhsr008.pdf).
30. Goyal M, Hersh A, Luan X, Localio R, Trent M, Zaoutis T. National trends in pelvic inflammatory disease among adolescents in the emergency department. J Adolesc Health 2013;53:249-52.
31. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2012. Atlanta: Department of Health and Human Services, 2013 (http://www.cdc.gov/std/stats12/surv2012.pdf)
32. Sexually transmitted infections in Europe 1990-2010. Stockholm: European Center for Disease Prevention and Control, 2013 (http://ecdc.europa.eu/en/publications/Publications/201206-Sexually-Transmitted-Infections-Europe-2010.pdf).
33. Centers for Disease Control and Prevention. Pelvic inflammatory disease: STD treatment guidelines. Atlanta: Department of Health and Human Services, 2010 (http://www.cdc.gov/std/treatment/2010/pid.htm).
34. Eschenbach DA, Wölner-Hanssen P, Hawes SE, Pavletic A, Paavonen J, Holmes KK. Acute pelvic inflammatory disease: associations of clinical and laboratory findings with laparoscopic findings. Obstet Gynecol 1997;89:184-92.
35. Wiesenfeld HC, Sweet RL, Ness RB, Krohn MA, Amortegui AJ, Hillier SL. Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis 2005;32:400-5.
36. Brunham RC, Maclean IW, Binns B, Peeling RW. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis 1985;152:1275-82.
37. Robertson JN, Ward ME, Conway D, Caul EO. Chlamydial and gonococcal antibodies in sera of infertile women with tubal obstruction. J Clin Pathol 1987;40:377-83.
38. Wølner-Hanssen P. Silent pelvic inflammatory disease: is it overstated? Obstet Gynecol 1995;86:321-5.
39. Brunham RC, Paavonen J, Stevens CE, et al. Mucopurulent cervicitis - the ignored counterpart in women of urethritis in men. N Engl J Med 1984;311:1-6.
40. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
41. Peipert JF, Boardman L, Hogan JW, Sung J, Mayer KH. Laboratory evaluation of acute upper genital tract infection. Obstet Gynecol 1996;87:730-6.
42. Weström L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility: a cohort study of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992;19:185-92.
43. Molander P, Finne P, Sjöberg J, Sellors J, Paavonen J. Observer agreement with laparoscopic diagnosis of pelvic inflammatory disease using photographs. Obstet Gynecol 2003;101:875-80.
44. Sellors J, Mahony J, Goldsmith C, et al. The accuracy of clinical findings and laparoscopy in pelvic inflammatory disease. Am J Obstet Gynecol 1991;164:113-20.
45. Vicetti Miguel RD, Chivukula M, Krishnamurti U, et al. Limitations of the criteria used to diagnose histologic endometritis in epidemiologic pelvic inflammatory disease research. Pathol Res Pract 2011;207:680-5.
46. Molander P, Sjoberg J, Paavonen J, Cacciatore B. Transvaginal power Doppler findings in laparoscopically proven acute pelvic inflammatory disease. Ultrasound Obstet Gynecol 2001;17:233-8.
47. Tukeva TA, Aronen HJ, Karjalainen PT, Molander P, Paavonen T, Paavonen J. MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology 1999;210:209-16.
48. Sakhel K, Benson CB, Platt LD, Goldstein SR, Benacerraf BR. Begin with the basics: role of 3-dimensional sonography as a first-line imaging technique in the cost-effective evaluation of gynecologic pelvic disease. J Ultrasound Med 2013;32:381-8.
49. Cohen CR, Sinei S, Reilly M, et al. Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study. J Infect Dis 1998;178:1352-8.
50. Kirkcaldy RD, Bolan GA, Wasserheit JN. Cephalosporin-resistant gonorrhea in North America. JAMA 2013;309:185-7.
51. Seña AC, Lensing S, Rompalo A, et al. Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis infections in men with nongonococcal urethritis: predictors and persistence after therapy. J Infect Dis 2012;206:357-65.
52. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol 2002;186:929-37.
53. Dhasmana D, Hathorn E, McGrath R, Tariq A, Ross JD. The effectiveness of nonsteroidal anti-inflammatory agents in the treatment of pelvic inflammatory disease: a systematic review. Syst Rev 2014;3:79.
54. Tepper NK, Steenland MW, Gaffield ME, Marchbanks PA, Curtis KM. Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review. Contraception 2013;87:655-60.
55. Ness RB, Trautmann G, Richter HE, et al. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol 2005;106:573-80.
56. Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W Jr, Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993;168:1503-9.
57. Gottlieb SL, Xu F, Brunham RC. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials. Sex Transm Dis 2013;40:97-102.
58. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-6.
59. Zakher B, Cantor AG, Pappas M, Daegas M, Nelson HD. Screening for gonorrhea and chlamydia: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2014;161:884-93.
60. Ness RB, Randall H, Richter HE, et al. Condom use and the risk of recurrent pelvic inflammatory disease, chronic pelvic pain, or infertility following an episode of pelvic inflammatory disease. Am J Public Health 2004;94:1327-9.
61. Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005;352:676-85.
62. Darville T. Pelvic inflammatory disease: identifying research gaps - proceedings of a workshop sponsored by Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases, November 3-4, 2011. Sex Transm Dis 2013; 40:761-7.
63. Paavonen J, Miettinen A, Heinonen PK, et al. Serum CA 125 in acute pelvic inflammatory disease. Br J Obstet Gynaecol 1989;96:574-9.
64. Tsai HT, Lee TH, Yang SF, Lin LY, Tee YT, Wang PH. Markedly elevated soluble E-cadherin in plasma of patient with pelvic inflammatory disease. Fertil Steril 2013;99:490-5.
65. Reighard SD, Sweet RL, Vicetti Miguel C, et al. Endometrial leukocyte subpopulations associated with Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis genital tract infection. Am J Obstet Gynecol 2011;205(4):324.e1-324.e7.
66. Burnett AM, Anderson CP, Zwank MD. Laboratory-confirmed gonorrhea and/or chlamydia rates in clinically diagnosed pelvic inflammatory disease and cervicitis. Am J Emerg Med 2012;30:1114-7.
67. Global incidence and prevalence of selected curable sexually transmitted infections - 2008. Geneva: World Health Organization, 2012 (http://www.who.int/reproductivehealth/publications/rtis/stisestimates/en/index.html).
68. Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2011 Assisted reproductive technology fertility clinic success rates report. Atlanta: Department of Health and Human Services, 2013 (http://www.cdc.gov/art/pdf/2011-report/fertility-clinic/art-2011-clinic-reportfull.pdf).
69. Cates W, Farley TM, Rowe PJ. Worldwide patterns of infertility: is Africa different? Lancet 1985;2:596-8.
70. Dhont N, van de Wijgert J, Vyankandondera J, Busasa R, Gasarabwe A, Temmerman M. Results of infertility investigations and follow-up among 312 infertile women and their partners in Kigali, Rwanda. Trop Doct 2011;41:96-101.
71. Peeling RW. Applying new technologies for diagnosing sexually transmitted infections in resource-poor settings. Sex Transm Infect 2011;87:Suppl 2:ii28-ii30.
72. Broutet N, Fruth U, Deal C, Gottlieb SL, Rees H. Vaccines against sexually transmitted infections: the way forward. Vaccine 2014;32:1630-7.
73. Brunham RC, Rappuoli R. Chlamydia trachomatis control requires a vaccine. Vaccine 2013;31:1892-7.